Hematology

The American Society of Hematology Announces New Honorific Award

WASHINGTON, July 16 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH) announces the debut of the Ernest Beutler Lecture and Prize, to be awarded at ASH's annual meeting in December. The inaugural recipients are Thomas Maniatis, PhD, of Harvard University, and Yuet Wai Kan, M...

American Society of Hematology awards grants to encourage novel medical training programs

(WASHINGTON, July 13, 2009) The American Society of Hematology (ASH) announces that Ellis J. Neufeld, MD, PhD, of Harvard Medical School, Thomas Shea, MD, of University of North Carolina at Chapel Hill, and Alvin Schmaier, MD, of Case Western Reserve University in Cleveland, will each receive ASH...

Minority Medical Students Receive Support to Pursue Hematology Research

WASHINGTON, June 5 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH) announces the selection of 15 participants for its 2009 Minority Medical Student Award Program (MMSAP), which encourages minority medical students to pursue an interest in hematology research. Under the program,...

ASH and EHA Jointly Announce Translational Research Training in Hematology Program

BERLIN, June 5 /PRNewswire-USNewswire/ -- In an effort to foster global biomedical research that will ultimately lead to new and improved treatments for patients with blood diseases, the American Society of Hematology (ASH) and the European Hematology Association (EHA) have collaborated to create ...

Minority medical students receive support to pursue hematology research

(WASHINGTON, June 4, 2009) The American Society of Hematology (ASH) announces the selection of 15 participants for its 2009 Minority Medical Student Award Program (MMSAP), which encourages minority medical students to purse an interest in hematology research. Under the program, each award recipie...

ASH and EHA jointly announce translational research training in hematology program

(BERLIN, June 5, 2009) In an effort to foster global biomedical research that will ultimately lead to new and improved treatments for patients with blood diseases, the American Society of Hematology (ASH) and the European Hematology Association (EHA) have collaborated to create the Translational ...

American Society of Hematology Urges Congress to Increase FY2010 NIH Funding by at least 7 Percent, Calls on Public to Join Effort

The American Society of Hematology is working with patient groups to increase federal funding of the National Institutes of Health by encouraging consumers to watch a short video that illuminates the life-saving potential of biomedical research and use the Society's online advocacy tool to contac...

ASH and HVO partner to launch hematology program in Peru

(WASHINGTON, March 27, 2009) Following the success of a program established in Uganda last year, the American Society of Hematology (ASH) and Health Volunteers Overseas (HVO) have again partnered to launch a new hematology program together with the Peruvian Social Security Health System, Empresa ...

ASH and HVO Partner to Launch Hematology Program in Peru

WASHINGTON, March 27 /PRNewswire-USNewswire/ -- Following the success of a program established in Uganda last year, the American Society of Hematology (ASH) and Health Volunteers Overseas (HVO) have again partnered to launch a new hematology program together with the Peruvian Social Security Healt...

Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument

ABBOTT PARK, Ill., Feb. 11 /PRNewswire-FirstCall/ -- Abbott ( NYSE: ABT ) today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new, compact hematology instrument, CELL-DYN Emerald(TM). Abbott's CELL-DYN Emerald will expand the company's hemat...

Hematology in Medical Technology

Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL

Data Showed Campath May Lead to Overall Survival in Patients with Poor Prognostic Factors SAN FRANCISCO, Dec. 9 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. today announced results from three studies showing that treatment with Campath(R) (alemtuzumab) showed activity in high-ris...

Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting

SAN FRANCISCO, Dec. 6 /PRNewswire-USNewswire/ -- Four studies highlighting late-breaking research advances in the treatment of cancer and sickle cell disease will be presented today at the 50th Annual Meeting of the American Society of Hematology in San Francisco, CA. Results from a study...

Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association

Data from Phase 1 Single Agent and Phase 1b Combination Clinical Trials Demonstrate Voreloxin's Anti-Leukemic Activity SOUTH SAN FRANCISCO, Calif., June 16 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) presented data Saturday from two clinical trials of t...

Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting

Three-fold Lower Incidence of Severe Cardiac Toxicity With Equivalent Complete Remission Rates Reported ATLANTA, Dec. 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) announced today that preliminary data from its phase II/III randomized stu...

Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting

Preliminary results demonstrate patients with chronic idiopathic thrombocytopenic purpura increased and maintained platelet counts at greater than or equal to 50,000/microliters with extended treatment ATLANTA, Dec. 10 /PRNewswire-USNewswire/ -- GlaxoSmithKline today announced data on the ...

Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting

ATLANTA, Dec. 7 /PRNewswire/ -- Ortho Biotech today announced that 12 clinical studies of DOXIL(R) (doxorubicin HCl pegylated liposome injection) will be presented at the 49th annual meeting of the American Society of Hematology (ASH) at the Georgia World Congress Center on December 8-11, 2007...

Genoptix, Inc. Announces Availability of MPL W515 L/K Mutation Analysis for MPD at 49th Annual American Society of Hematology (ASH) Meeting

SAN DIEGO, Dec. 7 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a provider of personalized diagnostic services, announced today at the ASH Meeting in Atlanta, Georgia, that it will launch testing for the MPL W515 L/K mutation. This new test further expands the Genoptix service offer...

PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting

ATLANTA, Dec. 6 /PRNewswire/ -- Data from 11 PROCRIT(R) (Epoetin alfa) studies will be presented at the American Society of Hematology (ASH) 49th Annual Meeting and Exposition December 8 - 11, 2007. The data will provide important insights including: -- the potential impact on the nati...

Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting

Company to Hold Conference Call on Monday, December 10, 2007 NEW HAVEN, Conn., Dec. 6 /PRNewswire-FirstCall/ -- Vion Pharmaceuticals, Inc. (Nasdaq: VION ) today announced that preliminary data from its pivotal Phase II trial of Cloretazine(R) (VNP40101M) in elderly patients with de novo...

Genta Clinical Programs Featured at American Society of Hematology Meeting

Phase 3 CLL Survival Analysis Selected for ASH Press Briefing BERKELEY HEIGHTS, N.J., Dec. 4 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA ) announced that several abstracts related to the Company's clinical programs will be featured at the annual meeting of the American Soc...

Hematology in Medical Products

Para 12 Plus Hematology Control

Description: Para 12 Plus is a hematology control for the Abbott CELL-DYN 3000, 3200, and 3500/3700. Assay values are provided for the five-part white cell differential, as well as a three-part differential on the CELL-DYN 1600 and 1700. Open-vial stability is seven days and closed-vial stability is 75 days. Pa...
Company:Streck

Para 12 Whole Blood Hematology Control, Three-part Differential

Description: Para 12 is a three-part differential control assayed for all parameters on the Coulter S Series, STKR, J Series, T Series, AcT/AcT diff/AcT diff2, MD Series and ONYX Series; Abbott CELL-DYN 1400, 1500, 1600, 1700, and 1800; Danam Datacell18, Datacell 18MS/18MS Plus, Datacell 16CP and Excell 16; Inf...
Company:Streck

Para 12 Extend Whole Blood Hematology Control, Three-part Differential

Description: Para 12 Extend is a three-part differential control assayed for all parameters on the Coulter S Series, STKR, J Series, T Series, AcT/AcT diff/AcT diff2, MD Series and ONYX Series; Abbott CELL-DYN 1400, 1500, 1600, 1700, and 1800; ABX Micros 60; and Diatron Abacus and Abacus Junior. Para 12 Extend ...
Company:Streck

Para 5X Whole Blood Hematology Control, Five-part Differential

Description: Para 5X is a whole blood hematology control manufactured specifically for the ABX Pentra 60C+, 80 and 120, and the Coulter AcT5diff instruments. The composition of this product offers a unique white cell differential, positioning the populations within the limitations of the algorithms on the syste...
Company:Streck

ABX Micros IM Hematology Analyzers

Description: ABX Micros IM Hematology Analyzer for a rapid diagnostic...
Company:Horiba ABX

BC-3200 Auto Hematology Analyzer

Description: ...
Company:Mindray

Excell 22 Hematology Analyzer

Description: 5 Part Differential Auto Hematology Analyzer. Top of the range Cell Counter for medium-sized laboratories....
Company:Drew Scientific

Excell™ 18 Hematology System

Description: Drew Scientific has been making leading edge and top quality CBC systems for over 15 years. The Excell 16/18 offers a reliable alternative for a 3 part differential....
Company:Drew Scientific

Excell 16 Hematology System

Description: Drew Scientific has been making leading edge and top quality CBC systems for over 15 years. The Excell 16/18 offers a reliable alternative for a 3 part differential....
Company:Drew Scientific

Evolution Hematology System

Description: Drew Scientific has been making leading edge, top quality CBC systems for over 15 years. The Evolution offers all the features of the Excell 16 with the new addition of primary sample tube cap piercing....
Company:Drew Scientific

More>>

Hematology in Medical Definition

Hematopathology

...- Chromatography - Flow cytometry - Blood bank - Microbiological culture - Serology v • d • e Pathology : hematology / hematological malignancy (primarily C81-C96 , D50-D77 ) White blood cells Lymphoid : Lymphoid leukaemia ( ALL , CLL , HCL ) • ...

Pathology

...ubspecialty, chemical pathology , in the U.S.) hematology and Flow cytometry (Part of a board-certifiable subspecialty, hematology , in the U.S.) Blood banking / Transfusion medi...diology - Endocrinology - Gastroenterology - hematology - Infectious disease - Intensive care medicine...

Medicine

...y Endocrinology Gastroenterology hematology Infectious Diseases Intensive care med...crinology , pediatric gastroenterology , pediatric hematology , pediatric oncology , pediatric ophthalmology ,...diology - Endocrinology - Gastroenterology - hematology - Infectious disease - Intensive care medicine...

Hematology in Medical Dictionary

Hematology

Hematology , also spelled haematology, is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of... Web site for Hemat...

Transplantation

...transplantation of blood stem cells derived from the bone marrow or blood. Stem cell transplantation is a medical procedure in the fields of hematology and oncology, most... Find Transplantation Continuing Medical Education (CME), Transplantation medical ... Hepatitis C Virus Impacts Survival...

Leukopenia

...n the free online English dictionary and ... neutropenia - leukopenia in which the decrease is primarily in number of ... Pathology > Basic hematology > White Cell Disorders > Benign White Cell Disorders: Leukopenia ... Leukopenia refers to an abnormal decrease in the number of ... MedH...

Hematocrit

...unt. ... Whether hemoglobin or hematocrit is preferred depends on different needs and is ... Both hematocrit and hemoglobin are important hematology parameters for ... Cerebrospinal Fluid (CSF) Analysis, Cervical Cerclage, Cervical Cryotherapy, Cesarean Section, Chest Tube Insertion, Chest X R...

Blood disorders

... navigation, search ... only some blood disorders can be cured. ... hematology | Blood disorders | Subjects taught ... White Blood Cell Dis...in Prenatal Development of the Digestive Tract. Anemia. Aplastic Anemia ... hematology and Blood Disorders . Iron Deficiency Anemia. Leukemia ... Find out ...

Hematology in Biological News

Taste, odor intervention improves cancer therapy, according to Virginia Tech, Wake Forest study

...hnology Department, Pinar Omur-Ozbek, also of CEE, Yong Woo Lee of Virginia Tech's School of Biomedical Engineering and Glenn Lesser, a physician of hematology and oncology at Wake Forest. Their joint paper, "Taste and Odor Abnormalities in Cancer Patients", reports the "alteration of taste and smell in (c...

DNA repair mechanisms relocate in response to stress

...d lead to new targets for anti-cancer drugs that interfere with DNA repair, says Paul Doetsch, PhD, professor of biochemistry, radiation oncology, and hematology and oncology at Emory University School of Medicine. The results were published in the February 1 issue of Molecular and Cellular Biology . The jo...

Lancet study supports new, highly effective treatment for blood disorder

...; Bethan Psaila, from the department of haematology, Hammersmith Hospital, Imperial College School of Medicine, London, U.K.; Lidia Kovaleva, from the hematology Research Center, Moscow, Russia; Abdulgabar Salama, from Charit-Universittsmedizin, Berlin, Germany; Julian M. Jenkins, Debasish Roychowdhury, Bhabita...

Research shows cell's inactive state is critical for effectiveness of cancer treatment

...ls that lose p53 can actually be killed more readily than those that have p53 intact," said the study's senior author, Stephen Nimer, MD, Chief of the hematology Service and Member of the Molecular Pharmacology and Chemistry Program at MSKCC. "Our findings have important implications for developing therapeutic ...

UC Davis researchers find molecule that targets brain tumors

...ancer cells left behind and systemic chemotherapy to prevent spread to nearby tissues," said Kit Lam, senior author of the study and UC Davis chief of hematology and oncology. "It is unfortunate that this approach does not extend survival significantly. Most patients survive less than one year." To find new ...

UC Davis researchers exploring gene therapy to fight AIDS

... his latest research at the 50th annual meeting of the American Society for hematology in San Francisco on Sunday, December 6, 2008, from 6 to 8 p.m. at the Mosco...atural gene-therapy experiment," explained Bauer, an assistant professor of hematology and oncology and director of a good manufacturing practice (GMP) laboratory...

UC Davis researchers discover new drug target for inflammatory disease

...rresponsive immune system. The involvement of integrins to the inflammatory process is of particular interest to study co-author Kit Lam, chief of hematology and oncology with UC Davis Cancer Center. "These two and other integrins are found on cancer cells," Lam explained. "And inflammation certainly pl...

Weill Cornell science briefs June/July 2008

...n with the disease each year. The research is published in a recent issue of the journal Blood, the official publication of the American Society of hematology (ASH). In Cooley's anemia, hemoglobin -- the oxygen-carrying molecule on red blood cells -- is mutated and non-functioning, resulting in a low red-...

New technology enhances therapeutic potential of cord blood stem cells

...ansplantation Symposium, June 6-7 in Los Angeles. Kent W. Christopherson II, PhD, assistant professor of medicine and researcher in the Sections of hematology and Stem Cell Transplantation at Rush, is researching a CD26 Inhibitor, a small molecule enzyme inhibitor that enhances directional homing of stem cel...

Avoiding Spleen Removal for Cooley's Anemia SufferersAvoiding spleen removal for Cooley's anemia suf

... disease each year. The research is published in the latest online issue of the journal Blood, the official publication of the American Society of hematology (ASH). In Cooley's anemia, hemoglobin -- the oxygen-carrying molecule on red blood cells -- is mutated and non-functioning, resulting in a low red-...

Hematology in Biological Technology

Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association

SOUTH SAN FRANCISCO, Calif., June 8 /PRNewswire/ -- Proteolix, Inc. today announced data from ongoing Phase 2 and Phase 1b clinical trials of carfilzomib for the treatment of multiple myeloma at the 14th Congress of the European Hematology Association (EHA) in Berlin, Germany. Carfilzomib is the ...

Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress

PRINCETON, N.J., June 8 /PRNewswire/ -- Celator Pharmaceuticals today announced that new clinical and preclinical data demonstrating the extended therapeutic bioavailability and tumor cell selectivity of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in leukemia were presented at the 14th Co...

BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition

BIRMINGHAM, Ala., Dec. 5 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX ) announced today that the Company will present pre-clinical data on Forodesine HCl and BCX-4208, and clinical data on BCX-4208 at the 50th American Society of Hematology (ASH) Annual Meeting and Exposition...

Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting

SOUTH SAN FRANCISCO, Calif., Dec. 3 /PRNewswire/ -- Portola Pharmaceuticals, a biopharmaceutical company developing innovative drugs that provide significant advances in cardiovascular disease, inflammatory disease and cancer, today announced that data related to the Company's series of novel comp...

Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association

MONTREAL, June 14 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") today presented results on its orally-active PBI-1402 compound in clinical trial in patients with chemotherapy-induced anemia ("CIA") at the 13th Congress of the European Hematology Association held ...

Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution

MUNDELEIN, Ill., April 22 /PRNewswire/ -- Sysmex America, Inc. today announced the successful completion of Mercy Medical Center's (Canton, OH) beta studies for its integrated hematology and A1C automation solution. This first-of-kind solution, which combines the Sysmex HST-N hematology automa...

ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting

LEUVEN, Belgium, December 11 /PRNewswire-FirstCall/ -- - TB-402 Shows Clear Promise as a Stable Long-acting Anticoagulant for the Prevention of Thromboembolic Disorders. ThromboGenics NV (Euronext Brussels:THR), a biotechnology company focused on vascular and eye disease, announced that th...

49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases

ATLANTA, Dec. 5 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional association of blood specialists, expects more than 20,000 attendees at the 49th ASH Annual Meeting on December 8-11, 2007, at the Georgia World Congress Center in Atlanta. The...

Cinpathogen Brings Together Over 40 Shanghai Area Hospitals at the First Annual Cinpathogen Hematology Conference

SHANGHAI, China, Dec. 5 /PRNewswire/ -- Representatives from over 40 Shanghai area hospitals, more than double the expected attendance, took part in the first annual Cinpathogen Hematology Conference at Shanghai's Equatorial Hotel. The conference, hosted by Cinpathogen Inc. and chaired by Prof...

Three Astex Drug Candidates to be Presented at the 2007 American Society of Hematology Annual Meeting

CAMBRIDGE, England, November 29 /PRNewswire/ -- Astex Therapeutics Ltd. today announced that data on its drug candidates AT9283, AT7519 and AT9311 will be presented at the American Society of Hematology's 49th Annual Meeting and Exposition, 8-11th December 2007, at the Georgia World Congress C...

Hematology in Biological Dictionary

Platelets

...sense the presence of air and begin to break apart. ... Shop Barnes & Noble for " Platelets " by Alan D. Michelson. Find a wide selection of hematology books to choose from. Blood plays an important role in how our bodies function. ... What are Platelets ? Nutrients in the Blood. Diseases of the R...